Search
acetaminophen/hydrocodone (Anexsia, Lorcet, Lortab, Vicodin, Norco)
DEA-controlled substance: class 3.
To be rescheduled to DEA class 2.
Indications:
- pain
- combinations of acetaminophen & opiate no longer recommended due to risk of acetaminophen toxicity [3]
Contraindications:
pregnancy-category +
safety in lactation -
Caution: in patients with G6PD deficiency
Dosage:
500 mg acetaminophen _ 2.5 mg hydrocodone (Lortab)
- 1-2 tabs PO every 4-6 hours
500 mg acetaminophen + 5 mg hydrocodone
- 1-2 tabs PO every 4-6 hours
500 mg acetaminophen + 7.5 mg hydrocodone (Lortab)
- 1-2 tabs PO every 4-6 hours
650 mg acetaminophen + 7.5 mg hydrocodone
- 1 tab PO every 4-6 hours
650 mg acetaminophen + 10 mg hydrocodone (Lorcet)
- 1 tab PO every 4-6 hours.
325 mg acetaminophen + 10 mg hydrocodone
- 1 tab PO every 4-6 hours. (Norco)
Pharmacokinetics: elimination: liver > kidney
Dosage adjustment in renal failure:
creatinine clearance dosage
10-50 (mL/min) every 6 hours
< 10 (mL/min) every 8 hours (metabolites may accumulate)
Adverse effects:
1) rash
2) nausea/vomiting
3) blood dyscrasias
4) nephrotoxicity with chronic use
5) hepatotoxicity
6) drowsiness
7) respiratory depression is dose & tolerance-related
8) tolerance & dependence
9) constipation
10) acetaminophen toxicity
Drug interactions:
1) agents that increase acetaminophen hepatotoxicity
- carbamazepine, hydantoin, barbiturates, chronic alcohol use, rifampin
2) acetaminophen can elevate INR in patients takin warfarin
3) naloxone is a direct opiate antagonist
Mechanism of action:
1) see acetaminophen
2) see hydrocodone
Notes:
- counterfeit Norco containing fentanyl & promethazine, led to several hospitalizations in the San Francisco Bay Area in 2016 [5]
Interactions
drug interactions
drug adverse effects of opiates
General
narcotic combination
Database Correlations
PUBCHEM cid=3083537
References
- The Pharmacological Basis of Therapeutics, 9th ed.
Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Drug Information & Medication Formulary, Veterans Affairs,
Central California Health Care System, 1st ed., Ravnan et al
eds, 1998. - not on National VA formulary
- Geriatric Review Syllabus, 8th edition (GRS8)
Durso SC and Sullivan GN (eds)
American Geriatrics Society, 2013
- Department of Justice. Durg Enforcement Administration.
21 CFR Part 1308. [Docket No. DEA-389]
Schedules of Controlled Substances: Rescheduling of Hydrocodone
Combination Products from Schedule III to Schedule II.
https://s3.amazonaws.com/public-inspection.federalregister.gov/2014-19922.pdf
- Vo KT et al
Counterfeit Norco Poisoning Outbreak - San Francisco Bay Area,
California, March 25-April 5, 2016
MMWR. Early Release / April 26, 2016 / 65
http://www.cdc.gov/mmwr/volumes/65/wr/mm6516e1.htm
Components
acetaminophen (Tylenol, Paracematol, Panadol, Tempra, Datril, APAP, non-Aspirin)
hydrocodone; dihydrocodeinone (Zohydro ER, Hysingla ER)